Status:
COMPLETED
Acute-On-Chronic Liver Failure In Cirrhotic Patients
Lead Sponsor:
Sohag University
Conditions:
Cirrhosis, Liver
Eligibility:
All Genders
18-65 years
Brief Summary
Cirrhosis is a condition characterized by diffuse fibrosis, severe disruption of the intrahepatic arterial and venous flow, portal hypertension and, ultimately, liver cell failure. Traditionally, cirr...
Detailed Description
Cirrhosis is a condition characterized by diffuse fibrosis, severe disruption of the intrahepatic arterial and venous flow, portal hypertension and, ultimately, liver cell failure. Traditionally, cirr...
Eligibility Criteria
Inclusion
- Cirrhotic patients whether compensated or decompensated with an acute decompensation of cirrhosis which is defined by the recent development of ascites, encephalopathy, GI haemorrhage, bacterial infection, or any combination of these
Exclusion
- no exclusion criteria
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT04790435
Start Date
March 1 2021
End Date
February 1 2022
Last Update
May 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag University
Sohag, Egypt